YLC EVENT: Is San Francisco a “Soft Target?”

August 10, 2016
222 Columbus Ave San Francisco, CA 94133 USA
150320221647327779

PRI’s Young Leaders Circle and National Review Institute present an evening with
Andrew C. McCarthy

How safe are we in San Francisco from the kind of soft-target attacks that are increasingly being carried out by terrorists?

Terrorism expert Andrew C. McCarthy will provide a special presentation for the members of the Young Leaders Circle.

WEDNESDAY, AUGUST 10, 2016

6pm Reception
7pm Program
Maritime Wine Tasting Studio
222 Columbus Avenue, San Francisco

Andrew C. McCarthy is a bestselling author, senior fellow at National Review Institute and a contributing editor for National Review Online. Andy is a former Chief Assistant United States Attorney in New York, best known for leading the 1995 terrorism prosecution against Sheikh Omar Abdel Rahman & eleven other jihadists waging a war against the United States – including the 1993 World Trade Center bombing & planning a series of attacks against New York City landmarks. He also prosecuted terrorists who bombed US embassies in Kenya and Tanzania.

Featuring music by The Haute Harpist/ Erica Messer

Young Leaders Circle Members Only

For more information, please contact Stephanie Watson at [email protected]
or call (415) 955-6143

About National Review Institute
The National Review Institute was founded by William F. Buckley Jr. in 1991, 36 years after he founded National Review magazine. The Institute is a non-profit, 501(c)(3), charitable organization, established to complement its sister organization, National Review, by engaging in policy development, public education, and advocacy to advance the conservative principles Buckley championed.

Tell Your Friends

Related

NextRoundSquare1600L NoBranding

2026 End of Session Preview

As lawmakers enter the final week of the 2026 legislative session, Tim and Matt are joined for Next Round’s annual look at the end of ...
Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

The sneaky, unregulated dangers of copycat GLP-1 drugs

Federal regulators are turning up the heat on sellers of copycat weight-loss drugs. Earlier this summer, the Food and Drug Administration sent warning letters to ...

Why Hospital Prices Keep Rising—And How Competition Can Help

Prescription drug prices fell 3.1% over the past year, the sharpest annual decline in more than six decades, according to new data from the federal ...
Scroll to Top